160 related articles for article (PubMed ID: 9309400)
41. Barrett's esophagus: a retrospective analysis of 13 years surveillance.
Switzer-Taylor V; Schlup M; Lübcke R; Livingstone V; Schultz M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1362-7. PubMed ID: 18205769
[TBL] [Abstract][Full Text] [Related]
42. Barrett's oesophagus and development of dysplasia and adenocarcinoma.
Faris F; Sampliner RE
Gut; 1993 Sep; 34(9):1292. PubMed ID: 8280240
[No Abstract] [Full Text] [Related]
43. Management of Nodular Neoplasia in Barrett's Esophagus: Endoscopic Mucosal Resection and Endoscopic Submucosal Dissection.
Belghazi K; Bergman JJGHM; Pouw RE
Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):461-470. PubMed ID: 28577767
[TBL] [Abstract][Full Text] [Related]
44. Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium.
Levine DS; Reid BJ; Haggitt RC; Rubin CE; Rabinovitch PS
Gastroenterology; 1989 Feb; 96(2 Pt 1):355-67. PubMed ID: 2910757
[TBL] [Abstract][Full Text] [Related]
45. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
Phillips RW; Frierson HF; Moskaluk CA
Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
[TBL] [Abstract][Full Text] [Related]
46. Antagonist: endoscopic surveillance of patients with Barrett's oesophagus.
Playford RJ
Gut; 2002 Sep; 51(3):314-5. PubMed ID: 12171949
[No Abstract] [Full Text] [Related]
47. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.
Edwards MJ; Gable DR; Lentsch AB; Richardson JD
Ann Surg; 1996 May; 223(5):585-9; discussion 589-91. PubMed ID: 8651749
[TBL] [Abstract][Full Text] [Related]
48. Surgical management of Barrett's esophagus.
Clark GW; DeMeester TR
Ann Chir Gynaecol; 1995; 84(2):139-44. PubMed ID: 7574371
[TBL] [Abstract][Full Text] [Related]
49. Protagonist: endoscopic surveillance of patients with Barrett's oesophagus.
Barr H
Gut; 2002 Sep; 51(3):313-4. PubMed ID: 12171948
[No Abstract] [Full Text] [Related]
50. Fluorescence in situ hybridization of cytologic specimens from Barrett's esophagus: a pilot feasibility study.
Falk GW; Skacel M; Gramlich TL; Casey G; Goldblum JR; Tubbs RR
Gastrointest Endosc; 2004 Aug; 60(2):280-4. PubMed ID: 15278064
[TBL] [Abstract][Full Text] [Related]
51. Brush cytology vs. endoscopic biopsy for the surveillance of Barrett's esophagus.
Kumaravel A; Lopez R; Brainard J; Falk GW
Endoscopy; 2010 Oct; 42(10):800-5. PubMed ID: 20821361
[TBL] [Abstract][Full Text] [Related]
52. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
[TBL] [Abstract][Full Text] [Related]
53. [Expression and clinical significance of the AgNOR and PCNA in Barrett's adenocarcinoma and its precancerous lesions].
Li H; Yao S; Stuart R
Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):286-8. PubMed ID: 7587897
[TBL] [Abstract][Full Text] [Related]
54. Barrett's esophagus, dysplasia, and adenocarcinoma.
Haggitt RC
Hum Pathol; 1994 Oct; 25(10):982-93. PubMed ID: 7927321
[TBL] [Abstract][Full Text] [Related]
55. Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium.
Sharma P; Katzka DA; Gupta N; Ajani J; Buttar N; Chak A; Corley D; El-Serag H; Falk GW; Fitzgerald R; Goldblum J; Gress F; Ilson DH; Inadomi JM; Kuipers EJ; Lynch JP; McKeon F; Metz D; Pasricha PJ; Pech O; Peek R; Peters JH; Repici A; Seewald S; Shaheen NJ; Souza RF; Spechler SJ; Vennalaganti P; Wang K
Gastroenterology; 2015 Nov; 149(6):1599-606. PubMed ID: 26296479
[TBL] [Abstract][Full Text] [Related]
56. Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit.
Moss A; Bourke MJ; Hourigan LF; Gupta S; Williams SJ; Tran K; Swan MP; Hopper AD; Kwan V; Bailey AA
Am J Gastroenterol; 2010 Jun; 105(6):1276-83. PubMed ID: 20179694
[TBL] [Abstract][Full Text] [Related]
57. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma.
Zhuang Z; Vortmeyer AO; Mark EJ; Odze R; Emmert-Buck MR; Merino MJ; Moon H; Liotta LA; Duray PH
Cancer Res; 1996 May; 56(9):1961-4. PubMed ID: 8616831
[TBL] [Abstract][Full Text] [Related]
58. Management of Barrett's esophagus with low-grade dysplasia.
Harrison M; Allen JE; Gorrepati VS; López-Jamar JME; Sharma P
Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29506235
[TBL] [Abstract][Full Text] [Related]
59. Utility of confocal laser endomicroscopy in identifying high-grade dysplasia and adenocarcinoma in Barrett's esophagus: a systematic review and meta-analysis.
Gupta A; Attar BM; Koduru P; Murali AR; Go BT; Agarwal R
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):369-77. PubMed ID: 24535597
[TBL] [Abstract][Full Text] [Related]
60. Barrett's esophagus. The cytology of dysplasia in comparison to benign and malignant lesions.
Wang HH; Doria MI; Purohit-Buch S; Schnell T; Sontag S; Chejfec G
Acta Cytol; 1992; 36(1):60-4. PubMed ID: 1546513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
